MAXONA Pharmaceuticals today announced that it has emerged from stealth with the completion of the U.S. Phase 1 clinical ...
The trial comes as a new study highlighted differences in how genes are activated in brain tumour cells compared to healthy ones.
MALVERN, Pa. - Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company trading near its 52-week low of $2.99, has announced the initiation of a Phase 3 trial for its Alzheimer's disease ...
The absolute number of new biologic drug approvals in any given year ... to London-based GlaxoSmithKline in late 2006. The entire development process, from generating a hybridoma cell line to ...
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...
MALVERN, PA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
A WOMAN who appeared to be asleep in a car containing class-A drugs has been given a jail sentence. Maria Todd, of North End Lane in Malvern, was sentenced to two years after appearing at ...
Temple Student Shot Dead ID'd, Second Student Arrested In Drug Deal Gone Wrong Near Campus A Temple University student was shot and killed in a drug deal gone wrong near the North Philadelphia campus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results